Biomarkers of (osteo)arthritis

References

• Abella V, Scotece M, Conde J, et al. (2015). The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1123354
   PubMedGoogle Scholar
• Archer CW, Francis-West P. (2003). The chondrocyte. Int J Biochem Cell Biol 35:401–4
   PubMed Web of Science ®Google Scholar
• Aspden RM, Scheven BA, Hutchison JD. (2001). Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism. Lancet 357:1118–20
   PubMed Web of Science ®Google Scholar
• Bauer DC, Hunter DJ, Abramson SB, et al. (2006). Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthr Cartil 14:723–7
   PubMed Web of Science ®Google Scholar
• Bay-Jensen AC, Reker D, Kjelgaard-Petersen CF, et al. (2016). Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria. Osteoarthr Cartil 24:9–20
   PubMed Web of Science ®Google Scholar
• Berenbaum F. (2013). Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr Cartil 21:16–21
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group. (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95
   PubMed Web of Science ®Google Scholar
• Bliddal H, Leeds AR, Christensen R. (2014). Osteoarthritis, obesity and weight loss: evidence, hypotheses and horizons - a scoping review. Obes Rev 15:578–86
   PubMed Web of Science ®Google Scholar
• Braun HJ, Gold GE. (2012). Diagnosis of osteoarthritis: imaging. Bone 51:278–88
   PubMed Web of Science ®Google Scholar
• Buckwalter JA, Mankin HJ. (1998). Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 47:487–504
   PubMedGoogle Scholar
• Chockalingam PS, Sun W, Rivera-Bermudez MA, et al. (2011). Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor. Osteoarthr Cartil 19:315–23
   PubMed Web of Science ®Google Scholar
• Collins FS, Varmus H. (2015). A new initiative on precision medicine. N Engl J Med 372:793–5
   PubMed Web of Science ®Google Scholar
• Conaghan PG. (2013). Osteoarthritis in 2012: parallel evolution of OA phenotypes and therapies. Nat Rev Rheumatol 9:68–70
   PubMed Web of Science ®Google Scholar
• Courties A, Gualillo O, Berenbaum F, Sellam J. (2015). Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthr Cartil 23:1955–65
   PubMed Web of Science ®Google Scholar
• Cross M, Smith E, Hoy D, et al. (2014). The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73:1323–30
   PubMed Web of Science ®Google Scholar
• Daghestani HN, Kraus VB. (2015). Inflammatory biomarkers in osteoarthritis. Osteoarthr Cartil 23:1890–6
   PubMed Web of Science ®Google Scholar
• De Lange-Brokaar BJ, Ioan-Facsinay A, van Osch GJ, et al. (2012). Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthr Cartil 20:1484–99
   PubMed Web of Science ®Google Scholar
• Dvir-Ginzberg M, Reich E. (2014). Chopping off the chondrocyte proteome. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2014.955884
   PubMedGoogle Scholar
• Felson DT, Anderson JJ, Naimark A, et al. (1988). Obesity and knee osteoarthritis. The Framingham study. Ann Intern Med 109:18–24
   PubMed Web of Science ®Google Scholar
• Felson DT, Niu J, Neogi T, et al. (2015). Synovitis and the risk of knee osteoarthritis: the MOST Study. Osteoarthr Cartil 12:177–90
   Google Scholar
• Greene MA, Loeser RF. (2015). Aging-related inflammation in osteoarthritis. Osteoarthr Cartil 23:1966–71
   PubMed Web of Science ®Google Scholar
• Haugen IK, Ramachandran VS, Misra D, et al. (2013). Hand osteoarthritis in relation to mortality and incidence of cardiovascular disease: data from the Framingham heart study. Ann Rheum Dis 74:74–81
   PubMed Web of Science ®Google Scholar
• Hedbom E, Antonsson P, Hjerpe A, et al. (1992). Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 267:6132–6
   PubMed Web of Science ®Google Scholar
• Henrotin Y, Clutterbuck AL, Allaway D, et al. (2010). Biological actions of curcumin on articular chondrocytes. Osteoarthr Cartil 18:141–9
   PubMed Web of Science ®Google Scholar
• Henrotin Y. (2012). Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview of research and initiatives. Osteoarthr Cartil 20:215–17
   PubMed Web of Science ®Google Scholar
• Henrotin Y, Sanchez C, Cornet A, et al. (2015). Soluble biomarkers development in osteoarthritis: from discovery to personalized medicine. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1123363
   Google Scholar
• Hunter DJ, Nevitt M, Losina E, Kraus V. (2014). Biomarkers for osteoarthritis: current position and steps towards further validation. Best Pract Res Clin Rheumatol 28:61–71
   PubMed Web of Science ®Google Scholar
• Jahr H, Brill N, Nebelung S. (2015a). Detecting early stage osteoarthritis by optical coherence tomography? Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1130190
   Google Scholar
• Jahr H, Matta C, Mobasheri A. (2015b). Physicochemical and biomechanical stimuli in cell-based articular cartilage repair. Curr Rheumatol Rep 17:22. DOI: 10.1007/s11926-014-0493-9
   PubMed Web of Science ®Google Scholar
• Kanis JA, Oden A, Johansson H, et al. (2009). FRAX and its applications to clinical practice. Bone 44:734–43
   PubMed Web of Science ®Google Scholar
• Kjelgaard-Petersen CF, Siebuhr AS, Christiansen T, et al. (2015). Synovitis biomarkers: ex vivo characterisation of three biomarkers for identification of inflammatory osteoarthritis. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1105497
   Google Scholar
• Kluzek S, Newton JL, Arden NK. (2015a). Is osteoarthritis a metabolic disorder? Br Med Bull 115:111–21
   PubMed Web of Science ®Google Scholar
• Kluzek S, Arden NK, Newton J. (2015b). Adipokines as potential prognostic biomarkers in patients with acute knee injury. Biomarkers 26:1–7
   Google Scholar
• Kluzek S, Bay-Jensen A-C, Judge A, et al. (2015c). Serum cartilage oligomeric matrix protein and development of radiographic and painful knee osteoarthritis. A community-based cohort of middle-aged women. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1105498
   PubMedGoogle Scholar
• Krawetz R, Ren G. (2015). Applying computation biology and “big data” to develop multiplex diagnostics for complex chronic diseases such as osteoarthritis. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1105499
   Google Scholar
• Lafeber FP, van Spil WE. (2013). Osteoarthritis year 2013 in review: biomarkers; reflecting before moving forward, one step at a time. Osteoarthr Cartil 21:1452–64
   PubMed Web of Science ®Google Scholar
• Larsson S, Englund M, Struglics A, Lohmander LS. (2012). The association between changes in synovial fluid levels of ARGS-aggrecan fragments, progression of radiographic osteoarthritis and self-reported outcomes: a cohort study. Osteoarthr Cartil 20:388–95
   PubMed Web of Science ®Google Scholar
• Lawrence RC, Helmick CG, Arnett FC, et al. (1998). Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778–99
   PubMed Web of Science ®Google Scholar
• Liu-Bryan R, Terkeltaub R. (2014). Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol 11:35–44
   PubMed Web of Science ®Google Scholar
• Lohmander LS, Saxne T, Heinegård DK. (1994). Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis 53:8–13
   PubMed Web of Science ®Google Scholar
• Lotz M, Martel-Pelletier J, Christiansen C, et al. (2013). Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis 72:1756–63
   PubMed Web of Science ®Google Scholar
• Louati K, Vidal C, Berenbaum F, Sellam J. (2015). Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis. RMD Open 1:e000077
   PubMed Web of Science ®Google Scholar
• Matta C, Zhang X, Liddell S, et al. (2015). Label-free proteomic analysis of the hydrophobic membrane protein complement in articular chondrocytes: a technique for identification of membrane biomarkers. Biomarkers. [Epub ahead of print]. DOI: 10.3109/1354750X.2015.1130191
   Google Scholar
• Mobasheri A, Matta C, Zákány R, Musumeci G. (2015). Chondrosenescence: definition, hallmarks and potential role in the pathogenesis of osteoarthritis. Maturitas 80:237–44
   PubMed Web of Science ®Google Scholar
• Mobasheri A. (2012). Osteoarthritis year 2012 in review: biomarkers. Osteoarthr Cartil 20:1451–64
   PubMed Web of Science ®Google Scholar
• Mobasheri A. (2013a). The future of osteoarthritis therapeutics: targeted pharmacological therapy. Curr Rheumatol Rep 15:364. DOI: 10.1007/s11926-013-0364-9
   PubMed Web of Science ®Google Scholar
• Mobasheri A. (2013b). The future of osteoarthritis therapeutics: emerging biological therapy. Curr Rheumatol Rep 15:385. DOI: 10.1007/s11926-013-0385-4
   PubMed Web of Science ®Google Scholar
• Orlowsky EW, Kraus VB. (2015). The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive. J Rheumatol 42:363–71
   PubMed Web of Science ®Google Scholar
• Prior JA, Jordan KP, Kadam UT. (2014). Associations between cardiovascular disease severity, osteoarthritis co-morbidity and physical health: a population-based study. Rheumatology 53:1794–802
   PubMed Web of Science ®Google Scholar
• Rashidifard C, Vercollone C, Martin S, et al. (2013). The application of optical coherence tomography in musculoskeletal disease. Arthritis 2013:563268
   PubMedGoogle Scholar
• Roos EM, Arden NK. (2015). Strategies for the prevention of knee osteoarthritis. Nat Rev Rheumatol 12:92–101
   PubMed Web of Science ®Google Scholar
• Rousseau JC, Delmas PD. (2007). Biological markers in osteoarthritis. Nat Clin Pract Rheumatol 3:346–56
   PubMedGoogle Scholar
• Rousseau JCH, Garnero P. (2012). Biological markers in osteoarthritis. Bone 51:265–77
   PubMed Web of Science ®Google Scholar
• Sandell LJ, Aigner T. (2001). Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res 3:107–13
   PubMedGoogle Scholar
• Sandell LJ. (2012). Etiology of osteoarthritis: genetics and synovial joint development. Nat Rev Rheumatol 8:77–89
   PubMed Web of Science ®Google Scholar
• Scanzello CR, Goldring SR. (2012). The role of synovitis in osteoarthritis pathogenesis. Bone 51:249–57
   PubMed Web of Science ®Google Scholar
• Scotece M, Mobasheri A. (2015). Leptin in osteoarthritis: focus on articular cartilage and chondrocytes. Life Sci 140:75–8
   PubMed Web of Science ®Google Scholar
• Sellam J, Berenbaum F. (2013). Is osteoarthritis a metabolic disease? Joint Bone Spine 80:568–73
   PubMed Web of Science ®Google Scholar
• Swan AL, Stekel DJ, Hodgman C, et al. (2015). A machine learning heuristic to identify biologically relevant and minimal biomarker panels from omics data. BMC Genomics 16:S2
   Google Scholar
• Wang Q, Rozelle AL, Lepus CM, et al. (2011). Identification of a central role for complement in osteoarthritis. Nat Med 17:1674–9
   PubMed Web of Science ®Google Scholar